LONGEVA.

5-Amino-1MQ: adverse events and evidence limits

In Neelakantan and colleagues’ study, 5-Amino-1MQ reduced 3T3-L1 cell viability at high concentrations after 24 hours of exposure. This is a laboratory cytotoxicity signal, not an established human adverse reaction. [1]

A separate experiment involved obese mice: nine per group, with subcutaneous administration for 11 days. That short experiment cannot establish human adverse-reaction frequencies or long-term safety. [1]

What the studies reported

EffectModel or participantsHow often or as describedSource
Reduced cell viability (in-vitro cytotoxicity)3T3-L1 cells, 24 hours of exposureAt high concentrations; a laboratory signal, not an established human adverse reaction; no frequency given[1]
Adverse reactions in the animal modelObese mice, nine animals per group, subcutaneous administration for 11 daysThe short experiment did not determine adverse-reaction frequencies; long-term safety in humans is not established[1]

References

  1. Neelakantan H, Vance V, Wetzel MD, Wang HL, McHardy SF, Finnerty CC, Hommel JD, Watowich SJ. (2018). Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice https://doi.org/10.1016/j.bcp.2017.11.007.